Paul Tudor Jones’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-57,454
Closed -$5.75K 3568
2025
Q4
$5.75K Hold
57,454
﹤0.01% 3422
2025
Q3
$34.8K Hold
57,454
﹤0.01% 3282
2025
Q2
$17.9K Hold
57,454
﹤0.01% 3173
2025
Q1
$28.1K Hold
57,454
﹤0.01% 2967
2024
Q4
$49.2K Buy
+57,454
New +$360K ﹤0.01% 2932

Paul Tudor Jones's APLT Position: Q1 2026 in Review

Paul Tudor Jones sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 57,454 shares — an estimated $5.75K sold.

Paul Tudor Jones first reported a position in APLT in Q4 2024 and held it in 5 quarters. The position peaked at $49.2K in Q4 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

  • Paul Tudor Jones reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 57,454 Applied Therapeutics shares in Q1 2026, an estimated $5.75K.
  • Paul Tudor Jones first reported a position in Applied Therapeutics in Q4 2024 and held it in 5 quarters.
  • Paul Tudor Jones's Applied Therapeutics position peaked at $49.2K in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.